[Therapeutically induced aldosteronism in hydropic cardiac insufficiency].
D000450:Aldosterone / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002247:Carbon Isotopes; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004232:Diuretics / Q000009:adverse effects*; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D008657:Metabolic Clearance Rate; D008722:Methods; D012636:Secretory Rate; D013148:Spironolactone / Q000009:adverse effects*; D014316:Tritium
D002247:Carbon Isotopes; D002301:Cardiac Glycosides; D004232:Diuretics; D014316:Tritium; D013148:Spironolactone; D000450:Aldosterone
Therapeutisch induzierter Aldosteronismus bei hydropischer Herzinsuffizienz.